|
Tabla 3: Distribución de comorbilidades por fallecimientos de casos confirmados y descartados de COVID-19 en mujeres menores de 19 años. |
||||
|
|
Casos confirmados |
Casos descartados |
||
|
Fallecidos n (%) |
No fallecidos n (%) |
Fallecidos n (%) |
No fallecidos n (%) |
|
|
Diabetes |
||||
|
Sí |
21 (7.37) |
287 (0.6) |
21 (3.38) |
672 (0.57) |
|
No |
264 (92.63) |
47,470 (99.4) |
601 (96.62) |
116,329 (99.43) |
|
χ2 (gl), p |
203.69 (1), < 0.0001 |
82.93 (1), < 0.0001 |
||
|
RM (IC95%) |
13.16 (8.31 a 20.83) |
6.05 (3.89 a 9.41) |
||
|
RM AGE (IC95%) |
13.77 (8.63 a 21.97) |
7.11 (4.55 a 11.10) |
||
|
EPOC |
||||
|
Sí |
0 (0) |
49 (0.1) |
2 (0.32) |
121 (0.1) |
|
No |
286 (100) |
47,715 (99.9) |
620 (99.68) |
116,887 (99.9) |
|
χ2 (gl), p |
*Z = 202.81, ≤ 0.0001 |
2.82 (1), 0.09 |
||
|
RM (IC95%) |
|
|
3.12 (0.77 a 12.63) |
|
|
RM AGE (IC95%) |
|
|
|
|
|
Asma |
||||
|
Sí |
6 (2.1) |
1,281 (2.68) |
11 (1.77) |
3,331 (2.85) |
|
No |
280 (97.9) |
46,479 (97.32) |
611 (98.23) |
113, 682 (97.15) |
|
χ2 (gl), p |
0.37 (1), 0.54 |
2.61 (1), 0.11 |
||
|
RM (IC95%) |
0.78 (0.35 a 1.75) |
0.61 (0.34 a 1.12) |
||
|
RM AGE (IC95%) |
0.84 (0.37 a 1.89) |
0.66 (0.36 a 1,21) |
||
|
Inmunosupresión |
||||
|
Sí |
29 (10.18) |
329 (0.69) |
75 (12.08) |
1,600 (1.37) |
|
No |
256 (89.82) |
47,352 (99.31) |
546 (87.92) |
115, 409 (98.63) |
|
χ2 (gl), p |
344.73 (1), < 0.0001 |
504.77 (1), < 0.0001 |
||
|
RM (IC95%) |
16.33 (10.96 a 24.33) |
9.91 (7.74 a 12.68) |
||
|
RM AGE (IC95%) |
12.75 (8.50 a 19.14) |
7.98 (6.22 a 10.23) |
||
|
Hipertensión |
||||
|
Sí |
21 (7.34) |
217 (0.45) |
18 (2.89) |
648 (0.55) |
|
No |
265 (92.66) |
47,547 (99.55) |
604 (97.11) |
116,376 (99.45) |
|
χ2 (gl), p |
273.70 (1), < 0.0001 |
60.19 (1), < 0.0001 |
||
|
RM (IC95%) |
17.36 (10.92 a 27.61) |
5.35 (3.33 a 8.61) |
||
|
RM AGE (IC95%) |
15.45 (9.63 a 24.78) |
5.37 (3.33 a 8.67) |
||
|
Enfermedad cardiovascular |
||||
|
Sí |
19 (6.64) |
246 (0.52) |
47 (7.56) |
994 (0.85) |
|
No |
267 (96.36) |
47,208 (99.48) |
575 (92.44) |
116,021 (99.15) |
|
χ2 (gl), p |
194.66 (1), < 0.0001 |
317.30 (1), < 0.0001 |
||
|
RM (IC95%) |
13.74 (8.49 a 22.26) |
9.54 (7.04 a 12.93) |
||
|
RM AGE (IC95%) |
11.35 (6.96 a 18.52) |
6.82 (5.01 a 9.27) |
||
|
Enfermedad renal crónica |
||||
|
Sí |
18 (6.29) |
118 (0.25) |
29 (4.67) |
541 (0.46) |
|
No |
268 (93.71) |
47,643 (99.75) |
592 (95.33) |
116, 487 (99.54) |
|
χ2 (gl), p |
368.26 (1), < 0.0001 |
226.82 (1), < 0.0001 |
||
|
RM (IC95%) |
27.12 (16.28 a 45.17 |
10.54 (7.20 a 15.46) |
||
|
RM AGE (IC95%) |
34.12 (19.81 a 58.75) |
12.11 (8.18 a 17.92) |
||
|
Obesidad |
||||
|
Sí |
21 (7.32) |
1,634 (3.42) |
22 (3.52) |
2,924 (2.5) |
|
No |
266 (92.68) |
46,130 (96.58) |
603 (9.65) |
114,101 (97.5) |
|
χ2 (gl), p |
13.02 (1), < 0.0001 |
2.66 (1), 0.1 |
||
|
RM (IC95%) |
2.23 (1.43 a 3.48) |
1.42 (0.93 a 2.18) |
||
|
RM AGE (IC95%) |
3.08 (1.96 a 4.85) |
2.26 1.47 a 3.48) |
||
|
Tabaquismo |
||||
|
Sí |
1 (0.35) |
323 (0.68) |
1 (0.16) |
906 (0.77) |
|
No |
285 (99.65) |
47,431 (99.32) |
621 (99.84) |
116,112 (99.23) |
|
χ2 (gl), p |
0.45 (1), 0.5 |
3.04 (1), 0.08 |
||
|
RM (IC95%) |
0.52 (0.07 a 3.68) |
0.21 (0.03 a 1.47) |
||
|
RM AGE (IC95%) |
1.30 (0.18 a 9.32) |
0.61 (0.09 a 4.35) |
||
|
RM = razón de momios, IC95% = intervalos de confianza al 95, RM AGE (IC95%) = razón de momios ajustada por grupo de edad (intervalos de confianza al 95), EPOC = enfermedad pulmonar obstructiva crónica. |
||||